Author: Sylvia A. Bullock
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 136
Book Description
FDA Medical Library Serials Holdings List
Author: Sylvia A. Bullock
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 136
Book Description
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 136
Book Description
FDA Medical Library Serials Holdings List
Author: United States. Food and Drug Administration. Medical Library
Publisher:
ISBN:
Category : Medical literature
Languages : en
Pages : 176
Book Description
Publisher:
ISBN:
Category : Medical literature
Languages : en
Pages : 176
Book Description
Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages :
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages :
Book Description
First multi-year cumulation covers six years: 1965-70.
FDA Medical Library Periodicals Holdings List
Author: United States. Food and Drug Administration. Medical Library
Publisher:
ISBN:
Category : Medical literature
Languages : en
Pages : 212
Book Description
Publisher:
ISBN:
Category : Medical literature
Languages : en
Pages : 212
Book Description
Guide to Microforms in Print
Author:
Publisher:
ISBN:
Category : Microforms
Languages : en
Pages : 798
Book Description
Publisher:
ISBN:
Category : Microforms
Languages : en
Pages : 798
Book Description
Protein Therapeutics, 2 Volume Set
Author: Tristan Vaughan
Publisher: John Wiley & Sons
ISBN: 3527340866
Category : Medical
Languages : en
Pages : 762
Book Description
Branchenführende Big-Pharma-Unternehmen und erstklassige Forscher präsentieren grundlegende Konzepte und Herausforderungen bei proteinbasierten Pharmazeutika. Beinhaltet auch eine Einführung in die aus Sicht der Arzneimittelentwicklung fünf wesentlichen Anwendungsbereiche.
Publisher: John Wiley & Sons
ISBN: 3527340866
Category : Medical
Languages : en
Pages : 762
Book Description
Branchenführende Big-Pharma-Unternehmen und erstklassige Forscher präsentieren grundlegende Konzepte und Herausforderungen bei proteinbasierten Pharmazeutika. Beinhaltet auch eine Einführung in die aus Sicht der Arzneimittelentwicklung fünf wesentlichen Anwendungsbereiche.
Therapeutic Monoclonal Antibodies
Author: Zhiqiang An
Publisher: John Wiley & Sons
ISBN: 1118210263
Category : Science
Languages : en
Pages : 932
Book Description
70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies. First book to address the discovery and development of antibody therapeutics in their entirety. Most chapters contain experimental data to illustrate the principles described in them. Authors provide detailed methodologies that readers can take away with them and use in their own laboratories.
Publisher: John Wiley & Sons
ISBN: 1118210263
Category : Science
Languages : en
Pages : 932
Book Description
70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies. First book to address the discovery and development of antibody therapeutics in their entirety. Most chapters contain experimental data to illustrate the principles described in them. Authors provide detailed methodologies that readers can take away with them and use in their own laboratories.
Therapeutic Antibody Engineering
Author: William R Strohl
Publisher: Elsevier
ISBN: 1908818093
Category : Medical
Languages : en
Pages : 697
Book Description
The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of engineering monoclonal antibodies and analyses the effect that various genetic engineering approaches will have on future candidates. Chapters in the first part of the book provide an introduction to monoclonal antibodies, their discovery and development and the fundamental technologies used in their production. Following chapters cover a number of specific issues relating to different aspects of antibody engineering, including variable chain engineering, targets and mechanisms of action, classes of antibody and the use of antibody fragments, among many other topics. The last part of the book examines development issues, the interaction of human IgGs with non-human systems, and cell line development, before a conclusion looking at future issues affecting the field of therapeutic antibody engineering. - Goes beyond the standard engineering issues covered by most books and delves into structure-function relationships - Integration of knowledge across all areas of antibody engineering, development, and marketing - Discusses how current and future genetic engineering of cell lines will pave the way for much higher productivity
Publisher: Elsevier
ISBN: 1908818093
Category : Medical
Languages : en
Pages : 697
Book Description
The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of engineering monoclonal antibodies and analyses the effect that various genetic engineering approaches will have on future candidates. Chapters in the first part of the book provide an introduction to monoclonal antibodies, their discovery and development and the fundamental technologies used in their production. Following chapters cover a number of specific issues relating to different aspects of antibody engineering, including variable chain engineering, targets and mechanisms of action, classes of antibody and the use of antibody fragments, among many other topics. The last part of the book examines development issues, the interaction of human IgGs with non-human systems, and cell line development, before a conclusion looking at future issues affecting the field of therapeutic antibody engineering. - Goes beyond the standard engineering issues covered by most books and delves into structure-function relationships - Integration of knowledge across all areas of antibody engineering, development, and marketing - Discusses how current and future genetic engineering of cell lines will pave the way for much higher productivity
Extracellular Vesicles as Next Generation Therapeutics
Author: Sylwia Bobis-Wozowicz
Publisher: Frontiers Media SA
ISBN: 2889763102
Category : Science
Languages : en
Pages : 163
Book Description
Publisher: Frontiers Media SA
ISBN: 2889763102
Category : Science
Languages : en
Pages : 163
Book Description
Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
Author: Ki-Young Lee
Publisher: Frontiers Media SA
ISBN: 2832526039
Category : Science
Languages : en
Pages : 123
Book Description
Publisher: Frontiers Media SA
ISBN: 2832526039
Category : Science
Languages : en
Pages : 123
Book Description